These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22270369)

  • 21. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies.
    Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH
    Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes.
    Haro C; Uribe ML; Quereda C; Cruces J; Martín-Nieto J
    Mol Vis; 2018; 24():43-58. PubMed ID: 29416295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice.
    Whitmore C; Fernandez-Fuente M; Booler H; Parr C; Kavishwar M; Ashraf A; Lacey E; Kim J; Terry R; Ackroyd MR; Wells KE; Muntoni F; Wells DJ; Brown SC
    Hum Mol Genet; 2014 Apr; 23(7):1842-55. PubMed ID: 24234655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy.
    Beedle AM; Turner AJ; Saito Y; Lueck JD; Foltz SJ; Fortunato MJ; Nienaber PM; Campbell KP
    J Clin Invest; 2012 Sep; 122(9):3330-42. PubMed ID: 22922256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fukutin-related protein alters the deposition of laminin in the eye and brain.
    Ackroyd MR; Whitmore C; Prior S; Kaluarachchi M; Nikolic M; Mayer U; Muntoni F; Brown SC
    J Neurosci; 2011 Sep; 31(36):12927-35. PubMed ID: 21900571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact.
    Bhattacharya S; Das A; Ghosh S; Dasgupta R; Bagchi A
    Gene; 2014 Mar; 537(1):108-14. PubMed ID: 24361964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of defective glycosylation in congenital muscular dystrophy.
    Schachter H; Vajsar J; Zhang W
    Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression.
    Gicquel E; Maizonnier N; Foltz SJ; Martin WJ; Bourg N; Svinartchouk F; Charton K; Beedle AM; Richard I
    Hum Mol Genet; 2017 May; 26(10):1952-1965. PubMed ID: 28334834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies.
    Ackroyd MR; Skordis L; Kaluarachchi M; Godwin J; Prior S; Fidanboylu M; Piercy RJ; Muntoni F; Brown SC
    Brain; 2009 Feb; 132(Pt 2):439-51. PubMed ID: 19155270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An atypical expression of core α-Dystroglycan and Laminin-α2 in skin fibroblasts of patients with congenital muscular dystrophies.
    Sabry S; Issa MY; Abdel-Hamid MS; Eissa NR; Abdel-Ghafar SF; Ibrahim MM; Zaki MS
    Mol Biol Rep; 2023 Aug; 50(8):6373-6379. PubMed ID: 37318662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice.
    Saito F; Masaki T; Saito Y; Nakamura A; Takeda S; Shimizu T; Toda T; Matsumura K
    J Neurochem; 2007 Jun; 101(6):1712-22. PubMed ID: 17326765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
    Manya H; Endo T
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.
    Vannoy CH; Xu L; Keramaris E; Lu P; Xiao X; Lu QL
    Hum Gene Ther Methods; 2014 Jun; 25(3):187-96. PubMed ID: 24635668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
    Saito Y; Yamamoto T; Ohtsuka-Tsurumi E; Oka A; Mizuguchi M; Itoh M; Voit T; Kato Y; Kobayashi M; Saito K; Osawa M
    Brain Dev; 2004 Oct; 26(7):469-79. PubMed ID: 15351084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
    Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
    Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.
    Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K
    Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation.
    Alhamidi M; Brox V; Stensland E; Liset M; Lindal S; Nilssen Ø
    Neuromuscul Disord; 2017 Jul; 27(7):619-626. PubMed ID: 28479227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
    Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional requirements for fukutin-related protein in the Golgi apparatus.
    Esapa CT; Benson MA; Schröder JE; Martin-Rendon E; Brockington M; Brown SC; Muntoni F; Kröger S; Blake DJ
    Hum Mol Genet; 2002 Dec; 11(26):3319-31. PubMed ID: 12471058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.